Command Palette

Search for a command to run...

Clinical Trials · NCT07554417

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

Not Yet RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Not Yet Recruiting
Sponsor
William Marsh Rice University
Enrollment
20
Start date
Apr 2026
Locations
1 site, United States
Primary endpoint
Change in Skeletal Muscle Mass
View Semaglutide compound reference